Medtronic, Inc.

Other

Steven M Goetz

Warren W Ball

Nathan Andrew Torgerson

Richard T Stone

Carl D Wahlstrand

Michael Thomas Lee

Jeffrey T Keacher

Andrew H Houchins

Gary William King

Wende L Dewing

Jon P Davis

Rajeev Madhukar Sahasrabudhe

Kenneth Timothy Heruth

Joseph J Nolan

James M Olsen

Gabriela C Molnar

Lynn M Otten

Roy L Testerman

Jordan J Greenberg

Martin T Gerber

Mark A Christopherson

Michael T Hegland

Touby Austin Drew

Shyam Gokaldas

Lynn A Davenport

Ashish Singal

Daniel K Vinup

Michael F Hoey

Todd V Smith

Gabriela C Miyazawa

Christopher Poletto

Eric J Panken

Donald R Johnson

Theodore J Stone

Mark S Lent

John Rondoni

Earle Timothy Roberts

Paul W Wacnik

Pedram Afshar

Ruth Elinor Bauhahn

Elizabeth A Fehrmann

Jiaying Shen

Gregory Pat Spar

Brent A Huhta

Jordan A Barnhorst

James M Hartmann

Scott R Stanslaski

Christopher L Pulliam

Timothy R Abraham

Mark J Holle

Christopher M Arnett

Sarah B Alme

Deborah A McConnell

Thomas L Chouinard

Shahram Malekkhosravi

Emem D Akpan

Lukas Valine

Evan Schnell

Alicia Weller Thompson

Ilan D Gordon

Karan Chitkara

Caleb C Zarns

Debbie A McConnell

Delight D DeMulling

Cari Herman

Andrew Ng

Hijaz M Haris

Ankush Thakur

Erik R Scott

Dennis M Skelton

Jamu Alford

Dwight E Nelson

Xuan K Wei

Gregory F Molnar

Duane L Bourget

Joel A Anderson

Jianping Wu

Spencer M Bondhus

John J Grevious

Jadin C Jackson

Irfan Z Ali

James Zimmerman

David C Ullestad

Leroy L Perz

Ajinkya M Joglekar

Spencer Fodness-Bondhus

David W Lee

Andrew N Csavoy

Wilbert Wesselink

Rahul Gupta

Jeffrey R Dixon

John D Welter

Kevin K Tidemand

Maciej T Lazarewicz

Jason D Rahn

Dennis J Bourget

Mark Salzwedel

Kevin M Johnson

Susan Heilman Kilbane

Shahram Malek

The disclosure is directed to programming implantable stimulators to deliver stimulation energy via one or more implantable leads having complex electrode array geometries. The disclosure also contemplates guided programming to select electrode combinations and parameter values to support efficacy. The techniques may be applied to a programming interface associated with a clinician programmer, a patient programmer, or both. A user interface permits a user to view electrodes from different perspectives relative to the lead. For example, the user interface provides a side view of a lead and a cross-sectional view of the lead. The user interface may include an axial control medium to select and/or view electrodes at different axial positions along the length of a lead, and a rotational control medium to select and/or view electrodes at different angular positions around a circumference of the lead.

Unwrapped 2D view of a stimulation lead with complex electrode array geometry

Devices, systems, and techniques are disclosed for managing electrical stimulation therapy and/or sensing of physiological signals such as brain signals. For example, a system may assist a clinician in identifying one or more electrode combinations for sensing a brain signal. In another example, a user interface may display brain signal information and values of a stimulation parameter at least partially defining electrical stimulation delivered to a patient when the brain signal information was sensed.

Brain stimulation and sensing

Techniques for remotely titrating a therapy delivered using an implantable medical device system are disclosed. An implantable medical device delivers therapy according to a first program. The system collects patient data relating to at least one of an efficacy of, or side effects resulting from, the delivered therapy, and transmits the patient data to a remote network device. A clinician may then analyze the patient data and determine if changes to the therapy are warranted. The clinician may then transmit a programming change, e.g., a modification to the first program or a new, second program, to the implantable medical device system, and the implantable medical device may deliver therapy according to the changed programming. The process of receiving patient data and modifying the therapy programming may be repeated multiple times until the therapy is adequately titrated, e.g., until the patient data indicates adequate efficacy and/or acceptable side effects.

Remote titration of therapy delivered by an implantable medical device

Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.

Peripheral nerve field stimulation control

An implantable nerve stimulator is implanted in a patient near a nerve target. The implantable nerve stimulator has a plurality of electrodes through which stimulation is provided to the nerve target. The relative location of the nerve target and the electrodes may be determined by applying stimulation to the nerves via each of the electrodes, determining an effect of the stimulation for each of the electrodes, and mapping a location of the nerve relative to the electrodes based on the effect of the stimulation for each of the electrodes.

Determining nerve location relative to electrodes

Electrode movement detection

Devices, systems, and techniques for mitigating error from gesture input are disclosed. A system may receive an indication of a first gesture input, determine that the first gesture input is an indicator gesture input, and, responsive to the determination that the first gesture input is the indicator gesture input, enter a gesture control mode during which the system is configured to control one or more actions related to a medical procedure. Only during the gesture control mode, the system may receive an indication of a second gesture input associated with the medical procedure and, responsive to receiving the indication of the second gesture input, control, based on the second gesture input, at least a portion of the medical procedure. Additionally, or alternatively, the system may employ other error mitigation techniques for gesture input related to medical procedures.

Systems and methods for mitigating gesture input error

A system for use in managing a neuromodulation therapy includes an ultrasound transducer array controlled by a control unit to deliver ultrasound waveforms for causing modulation of neural tissue in a patient. The system acquires data indicating a response to the modulation, analyzes the acquired data to determine correlation data between a response to the modulation and an ultrasound control parameter, and reports the correlation data to enable identification of at least one therapy parameter to be used to deliver a neuromodulation therapy to the patient by a therapy delivery system.

Ultrasound diagnostic and therapy management system and associated method

The disclosure describes a method and system that allows a user to configure electrical stimulation therapy by defining a three-dimensional (3D) stimulation field. After a stimulation lead is implanted in a patient, a clinician manipulates the 3D stimulation field in a 3D environment to encompass desired anatomical regions of the patient. In this manner, the clinician determines which anatomical regions to stimulate, and the system generates the necessary stimulation parameters. In some cases, a lead icon representing the implanted lead is displayed to show the clinician where the lead is relative to the 3D anatomical regions of the patient.

User interface with 3D environment for configuring stimulation therapy

Prophylactic stimulation and abortive electrical stimulation are delivered to a cranial nerve, including, e.g. an occipital or trigeminal nerve to treat symptoms of various conditions, including, e.g. occipital neuralgia or migraines.

Dual prophylactic and abortive electrical stimulation

In some examples, a burr hole cap assembly includes one or more markers that indicate a rotational orientation of a therapy delivery member relative to the burr hole cap assembly, where the therapy delivery member extends through an opening defined by the burr hole cap assembly. In addition, in some examples, the burr hole cap assembly includes a feature that indicates the rotational orientation of the therapy delivery member after the therapy delivery member is implanted in the patient. The feature can include the one or more markers in some examples.

Burr hole cap assembly with therapy delivery member orientation feature

Growing community of inventors

North Oaks, MN, United States of America

Steven M Goetz